Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis
From MaRDI portal
Publication:739328
DOI10.1016/j.jtbi.2015.06.041zbMath1343.92249OpenAlexW799664256WikidataQ41113913 ScholiaQ41113913MaRDI QIDQ739328
Oleg V. Demin, Neil Benson, Kirill V. Zhudenkov, Tatiana A. Karelina, Svetlana V. Vinogradova, Piet H. van der Graaf
Publication date: 18 August 2016
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2015.06.041
Uses Software
This page was built for publication: Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis